Life Science and Healthcare Advisory
Where Operators Advise Investors
What is your next value-creating move?
Operator-led insight. Investor-grade decisions. Enterprise-scale execution. We help healthcare and life sciences leaders think sharper, build stronger, and turn strategy into measurable value.
Founded in 2009
Built in the Boardroom and on the Shop Floor
Bio-nAbler empowers investors and operators to make sharper decisions, raise capital, build stronger operating models, and drive growth from diligence through post-acquisition value creation
From Laboratory to Market
Developed 6+ commercially approved biologics. Patents covering the global antibody market. Founded 7 biotech companies.
Investment Excellence
Deployed $2B+ in life sciences across 20+ deals with multiple successful exits.
Real P&L Ownership
CEOs who've built, scaled, and exited life science companies with $500–800M+ valuations.
From Laboratory to Market
Physicians who've treated patients, led 700-bed hospitals, and pioneered breakthrough therapies.
Regulatory Mastery
Taken 30 novel molecules into the clinic with 6 approved products including several $1bn+ blockbusters
Global Market Leadership
Country MDs and Regional Presidents who've led Pfizer, UCB, and built operations across 30+ countries.
Transaction Services and
Strategic Advisory
What We Do
Deep domain expertise paired with execution capability
across every stage of the investment lifecycle.
Due Diligence
Commercial, technical, and operational assessment. Management team evaluation. Synergy identification and quantification within compressed timelines.
M&A Corporate Development
Target identification, transaction structuring, integration planning, carve out management, and cross border transaction expertise.
Operational Excellence
Portfolio optimization, co-build & design, buy-and-build strategies, exit planning, partnership and licensing strategies grounded in operational experience.
Corporate Strategy
Cost optimization, revenue growth initiatives, digital transformation, new product development, innovation.
Post-Acquisition Value Creation
Integration planning and execution, 100-day plans, organizational restructuring, commercial excellence, and supply chain enhancement.
